van den Heerik, A. S. V. M., Horeweg, N., Nout, R. A., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Westerveld, G. H., van den Berg, H. A., Slot, A., Koppe, F. L. A., Kommoss, S., Mens, J. W. M., Nowee, M. E., Bijmolt, S., Cibula, D., Stam, T. C., Jurgenliemk-Schulz, I. M., Snyers, A., Hamann, M., Zwanenburg, A. G., Coen, V. L. M. A., Vandecasteele, K., Gillham, C., Chargari, C., Verhoeven-Adema, K. W., Putter, H., van den Hout, W. B., Wortman, B. G., Nijman, H. W., Bosse, T., & Creutzberg, C. L. (2020). pORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer. International journal of gynecological cancer, 30(12), 2002–2007. http://access.bl.uk/ark:/81055/vdc_100127580940.0x00005f